Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (PACTR202509763211872) titled 'Safety and efficacy of subconjunctival bevacizumab compared with placebo in the management of acquired cornea opacity with neovascularization' on Sept. 11.
Study Type: Interventional
Study Design:
Parallel: different groups receive different interventions at same time during study,Randomised,Simple randomization using by using procedures such as coin-tossing or dice-rolling,Sealed opaque envelopes
Primary Sponsor: Abe Adeola
Condition:
Eye Diseases
Recruitment Status: Not Recruiting
Phase: Phase-3
Date of First Enrollment: 01/10/2025
Target Sample Size: 64
Countries of Recruitment:
Nigeria
To...